Alle Storys
Folgen
Keine Story von LifeWatch AG mehr verpassen.

LifeWatch AG

EANS-Adhoc: LifeWatch AG to announce Full Fiscal Year 2009 and Fourth Quarter 2009 Results on February 24, 2010 - Press release at 7:00 a.m. CET - Analyst and media conference held in Zurich at 11:00 a.m. CET - International Live-Conference ...

  ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide
  distribution. The issuer is solely responsible for the content of this
  announcement.
annual report
05.02.2010
Neuhausen am Rheinfall / Switzerland - LifeWatch AG (SIX Swiss 
Exchange: LIFE) announces its results for the full fiscal year 2009 
and the fourth quarter 2009 on Wednesday, February 24, 2010 in 
Zurich.
The PDF-Version of this invitation and a registration form can be 
downloaded at:
http://www.newsaktuell.ch/pdf/registration_form.pdf
http://www.newsaktuell.ch/pdf/lifewatch_invite_q4_e.pdf
Press Release at 7:00 a.m. CET (1:00 a.m. EST) The results for the 
full fiscal year 2009 and the fourth quarter 2009 will be issued 
internationally at 7:00 a.m. CET.
Analysts´ and Media conference at 11:00 a.m. CET LifeWatch will 
report in detail on the full fiscal year 2009 and the fourth quarter 
2009 results at an English-speaking analysts´ and media conference 
which takes place in Zurich on
Wednesday, February 24, 2010; 11:00 a.m. CET,       at the Zunfthaus 
zur Saffran, Limmatquai 54, 8001 Zurich/Switzerland
Please confirm your participation at the analyst/media conference by 
returning the registration form by February 17, 2010.
International Live-Conference Call/Audio Webcast at 11:00 a.m. CET 
For international participants a combined conference call and audio 
webcast, accompanied by presentation visuals, is broadcasted online 
at 11:00 a.m CET (05:00 a.m. EST) live from the conference in Zurich.
Further information regarding the audio webcast and respective 
technical requirements can be found in the Investor Relations section
of the LifeWatch Website www.lifewatch.com in due time. An archived 
version of the webcast will remain available for download.
The local dial-in numbers for the conference call are as follows:
+ 41 (0)91 610 56 00 (Europe)
+ 44 (0)207 107 06 11 (UK)
+1 (1)866 291 41 66 (USA - Toll-free)
All participants should dial in at least ten minutes prior to the 
call. There is no PIN required to access the call.
end of ad-hoc-announcement
About LifeWatch AG
LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX Swiss
Exchange (LIFE), Switzerland, is the leading healthcare technology 
and solution company, specializing in advanced telehealth systems and
wireless remote patient monitoring services. LifeWatch services treat
high-risk and chronically ill patients, health conscious consumers 
and wellness programs. LifeWatch has subsidiaries in the United 
States, the Netherlands, Japan, the United Kingdom, Switzerland and 
Israel. LifeWatch AG is the parent company of LifeWatch Services 
Inc., a leading US-based cardiac monitoring service provider, and 
manufacturer of telecardiology products. LifeWatch is also 
introducing a new program for Home SleepTesting of Obstructive Sleep 
Apnea (OSA) patients under the brand name NiteWatch. For additional 
information, please visit www.lifewatch.com and 
www.nitewatchservices.com
Sign-up for customized E-mail alerts and documentation requests is 
available at
http://production.investis.com/lifewatch/alert-service/
This press release includes forward-looking statements. All 
statements other than statements of historical facts contained in 
this press release, including statements regarding future results of 
operations and financial position, business strategy and plans and 
objectives for future operations, are forward- looking statements. 
The words “believe,” “may,” “will,” “estimate,” “continue,” 
“anticipate,” “intend,” “expect” and similar expressions are intended
to identify forward-looking statements. LifeWatch AG has based these 
forward- looking statements largely on current expectations and 
projections about future events and financial trends that it believes
may affect the financial condition, results of operations, business 
strategy, short term and long term business operations and 
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light
of these risks, uncertainties and assumptions, the forward-looking 
events and circumstances described may not occur and actual results 
could differ materially and adversely from those anticipated or 
implied in the forward- looking statements. All forward-looking 
statements are based only on data available to LifeWatch AG at the 
time of the issue of this press release. LifeWatch AG does not 
undertake any obligation to update any forward-looking statements 
contained in this press release as a result of new information, 
future events or otherwise.
THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF 
AMERICA AND SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR 
PUBLICATIONS WITH A GENERAL CIRCULATION IN THE UNITED STATES.  THIS 
PRESS RELEASE DOES NOT CONSTITUTE AN OFFER OF SECURITIES OF LIFEWATCH
AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN THE UNITED STATES OR AN 
INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY SECURITIES OF LIFEWATCH 
AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN ADDITION, THE 
SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN 
REGISTERED UNDER THE UNITED STATES SECURITIES LAWS AND MAY NOT BE 
OFFERED, SOLD OR DELIVERED WITHIN THE UNITED STATES OR TO U.S. 
PERSONS ABSENT REGISTRATION UNDER OR AN APPLICABLE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS OF THE UNITED STATES SECURITIES LAWS.  ANY 
PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED STATES WILL BE
MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM LIFEWATCH AG 
OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED 
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL 
STATEMENTS OF THE ISSUER.
end of announcement                               euro adhoc

Further inquiry note:

Kobi Ben Efraim, Chief Financial Officer, LifeWatch AG
Tel +41 52 632 00 50 | Fax +41 52 632 00 51 | Email kobibe@lifewatch.com

Sensus Investor and Public Relations GmbH, Zürich:
Tel +41 43 366 55 11 | Fax +41 43 366 55 12 | Email lifewatch@sensus.ch

Branche: Healthcare Providers
ISIN: CH0012815459
WKN: 1281545
Index: SPI, SPIEX
Börsen: Frankfurt / Open Market / XETRA
SIX Swiss Exchange / Hauptsegment
Berlin / free trade

Weitere Storys: LifeWatch AG
Weitere Storys: LifeWatch AG